Posts

UTHealth Houston Secures $2.9M Grant to Revamp Clinical...

In a groundbreaking initiative aimed at addressing disparities in neurological o...

Scientists Develop Bacteria-Repellent Surfaces That Pro...

image:  The team have shown that their nanostructured surfaces resist the growth...

Scientists Develop Bacteria-Resistant Substrates That P...

Tokyo Metropolitan University has recently made a significant advancement in the...

Promising New Tablet Offers Hope for Controlling and Er...

A significant breakthrough in the treatment of soil-transmitted helminthiases ha...

Oculis’ Phase 2 Study Explores OCS-05 for Optic Nerve I...

A phase 2 clinical trial has assessed the effectiveness and safety of OCS-05, a ...

Portage packages Tarus’ adenosine receptor antagonists ...

Over two years after taking over Tarus Therapeutics, Portage Biotech is reintrod...

Novo Nordisk and Valo expand cardiometabolic drug partn...

Novo Nordisk has expanded its partnership with Valo Health to advance new therap...

Sanofi taps Alloy Therapeutics for CNS antisense drug d...

As part of the agreement, Sanofi will provide Alloy with upfront license fees an...

Clinical trial trends in 2025: Investment headwinds, we...

With clinical trials facing multiple challenges, digital solutions could provide...

MSD’s HPV vaccine gains China NMPA’s expanded approval ...

China's National Medical Products Administration has granted expanded approval t...

Newron and Myung In Pharm sign agreement for evenamide ...

Newron and Myung In Pharm have signed a licence agreement for evenamide, for sch...

Synaffix secures ADC deals with Boehringer and Mitsubis...

Synaffix adds to the flurry of ADC dealmaking as it partners with Boehringer and...

Samsung Biologics and LigaChem extend ADC services deal

Samsung Biologics has extended its collaboration with LigaChem Biosciences for a...

UK-based Verdiva launches with $410m and an oral GLP-1R...

Financing was co-led by Forbion and General Atlantic, with participants includin...

Palforzia’s peanut allergy treatment use in Europe expa...

The EC has approved the extension of Stallergenes Greer’s Palforzia for the trea...

Aspect Biosystems secures $115m to develop tissue thera...

Aspect Biosystems has secured $115m in a Series B financing round to advance the...